DK2924053T3 - Glycosyleret linker, forbindelse, der indeholder glycosyleret linker-del og fysiologisk aktiv stofdel eller salt deraf, og fremgangsmåder til fremstilling af forbindelsen eller saltet deraf - Google Patents
Glycosyleret linker, forbindelse, der indeholder glycosyleret linker-del og fysiologisk aktiv stofdel eller salt deraf, og fremgangsmåder til fremstilling af forbindelsen eller saltet deraf Download PDFInfo
- Publication number
- DK2924053T3 DK2924053T3 DK13857593.1T DK13857593T DK2924053T3 DK 2924053 T3 DK2924053 T3 DK 2924053T3 DK 13857593 T DK13857593 T DK 13857593T DK 2924053 T3 DK2924053 T3 DK 2924053T3
- Authority
- DK
- Denmark
- Prior art keywords
- links
- glycosyled
- glycosylated
- salts
- preparation
- Prior art date
Links
- 239000013543 active substance Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
- C07K17/02—Peptides being immobilised on, or in, an organic carrier
- C07K17/10—Peptides being immobilised on, or in, an organic carrier the carrier being a carbohydrate
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/549—Sugars, nucleosides, nucleotides or nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08H—DERIVATIVES OF NATURAL MACROMOLECULAR COMPOUNDS
- C08H1/00—Macromolecular products derived from proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
- A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012256947 | 2012-11-22 | ||
| PCT/JP2013/079408 WO2014080730A1 (ja) | 2012-11-22 | 2013-10-30 | 糖鎖付加リンカー、糖鎖付加リンカー部分と生理活性物質部分とを含む化合物またはその塩、及びそれらの製造方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2924053T3 true DK2924053T3 (da) | 2020-12-14 |
Family
ID=50775917
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK13857593.1T DK2924053T3 (da) | 2012-11-22 | 2013-10-30 | Glycosyleret linker, forbindelse, der indeholder glycosyleret linker-del og fysiologisk aktiv stofdel eller salt deraf, og fremgangsmåder til fremstilling af forbindelsen eller saltet deraf |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US9708413B2 (da) |
| EP (1) | EP2924053B1 (da) |
| JP (1) | JP6211533B2 (da) |
| KR (1) | KR102227918B1 (da) |
| CN (1) | CN104918962B (da) |
| DK (1) | DK2924053T3 (da) |
| TW (1) | TWI634127B (da) |
| WO (1) | WO2014080730A1 (da) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI660741B (zh) * | 2015-11-03 | 2019-06-01 | 財團法人工業技術研究院 | 抗體藥物複合物及其製造方法 |
| JP7404228B2 (ja) * | 2018-03-22 | 2023-12-25 | 持田製薬株式会社 | 非ステロイド性抗炎症性化合物結合アルギン酸誘導体 |
| JP7437578B2 (ja) * | 2019-03-20 | 2024-02-26 | 国立大学法人東北大学 | 新規オピオイドペプチド、その糖鎖付加体及びそれらを含む医薬組成物 |
| CN113501889A (zh) * | 2021-07-06 | 2021-10-15 | 郑州大学 | 一种三七多糖阳离子衍生物的制备方法及其应用 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0778081B2 (ja) * | 1990-07-19 | 1995-08-23 | 静岡大学長 | 機能化高分子の合成方法 |
| JP2604930B2 (ja) | 1990-12-14 | 1997-04-30 | 株式会社ディ・ディ・エス研究所 | ヒアルロン酸およびコンドロイチン誘導体 |
| JP2527885B2 (ja) * | 1992-09-02 | 1996-08-28 | 株式会社ディ・ディ・エス研究所 | ヘパリン誘導体 |
| ES2156611T3 (es) * | 1996-12-16 | 2001-07-01 | Nederlanden Staat | Metodo para acoplar polisacaridos a proteinas. |
| JP2001302695A (ja) | 2000-04-20 | 2001-10-31 | Asahi Kasei Corp | Ｇｌｎ結合型糖鎖付加カルシトニン誘導体 |
| US6441293B1 (en) | 2000-04-28 | 2002-08-27 | Labarbera Anthony | System for generating percussion sounds from stringed instruments |
| EP2481746A1 (en) | 2001-06-19 | 2012-08-01 | Otsuka Chemical Co., Ltd. | Process for producing sugar chain asparagine derivative |
| US20030096299A1 (en) | 2001-07-09 | 2003-05-22 | Valerie Wittamer | Natural ligand of G protein coupled receptor ChemR23 and uses thereof |
| US7943763B2 (en) | 2002-07-05 | 2011-05-17 | Otsuka Chemical Holdings Co., Ltd. | Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides |
| TWI335920B (en) | 2002-12-24 | 2011-01-11 | Yasuhiro Kajihara | Sugar chain asparagine derivatives, sugar chain asparagine and sugar chain and manufacture thereof |
| TWI247749B (en) | 2002-12-26 | 2006-01-21 | Yasuhiro Kajihara | 3 branch type saccharide chain asparagine derivative, saccharide chain asparagine there of, saccharide chain there of, and method for producing same |
| PT1591532T (pt) | 2003-02-04 | 2019-01-11 | Glytech Inc | Processo para produção de um derivado de asparagina de cadeia de açúcar |
| CA2843439A1 (en) | 2003-04-08 | 2004-10-21 | Yeda Research And Development Co. Ltd | Reversible pegylated drugs |
| JP4555823B2 (ja) | 2003-07-11 | 2010-10-06 | セラヴァンス， インコーポレーテッド | 架橋されたグリコペプチド−セファロスポリン抗生物質 |
| WO2005007694A1 (ja) | 2003-07-16 | 2005-01-27 | Green Peptide Co., Ltd. | ＨＥＲ２／ｎｅｕペプチドおよびその治療上の用途 |
| WO2005010053A1 (ja) | 2003-07-28 | 2005-02-03 | Otsuka Chemical Co., Ltd. | アミノ化複合型糖鎖誘導体及びその製造方法 |
| CN1832762B (zh) * | 2003-08-08 | 2012-09-05 | 弗雷泽纽斯卡比德国有限公司 | 羟烷基淀粉与g-csf的偶联物 |
| JP2007501870A (ja) * | 2003-08-08 | 2007-02-01 | フレゼニウス・カビ・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | ヒドロキシアルキルデンプンとｇ−ｃｓｆの複合体 |
| CN1310898C (zh) | 2004-01-19 | 2007-04-18 | 中国人民解放军军事医学科学院毒物药物研究所 | 紫杉醇水溶性衍生物 |
| AU2005229001A1 (en) | 2004-03-23 | 2005-10-13 | Amgen Inc. | Chemically modified protein compositions and methods |
| JPWO2005095331A1 (ja) | 2004-03-31 | 2008-02-21 | 塩野義製薬株式会社 | 糖鎖−ペプチド結合剤 |
| TW200643033A (en) * | 2005-03-08 | 2006-12-16 | Chugai Pharmaceutical Co Ltd | Conjugate of water-soluble modified hyaluronic acid and glp-1 analogue |
| TWI342880B (en) | 2005-07-19 | 2011-06-01 | Otsuka Chemical Co Ltd | Method for producing sugar chain derivatives, and sugar chain derivatives |
| RU2539829C2 (ru) * | 2007-06-19 | 2015-01-27 | ГЛИТЕК,ИНК.,Япония | Пептид glp-1 с присоединенной олигосахаридной цепью |
| EP2596805B1 (en) * | 2008-02-01 | 2021-10-27 | Ascendis Pharma A/S | Prodrug comprising a drug-linker conjugate |
| JP2009242372A (ja) | 2008-03-11 | 2009-10-22 | Yokohama City Univ | 均一な糖鎖構造を有するエリスロポエチン誘導体 |
| RU2543157C2 (ru) | 2008-06-17 | 2015-02-27 | Глитек,Инк. | Гликозилированный пептид glp-1 |
| US20110262945A1 (en) | 2008-08-19 | 2011-10-27 | Otsuka Chemical Co., Ltd. | Glycoprotein production method and screening method |
| JP2010229093A (ja) | 2009-03-27 | 2010-10-14 | Banyu Pharmaceut Co Ltd | 新規ＣｈｅｍｅｒｉｎＲアゴニスト |
| JPWO2011052523A1 (ja) * | 2009-10-30 | 2013-03-21 | 株式会社糖鎖工学研究所 | 抗原性ｇｌｐ−１アナログの糖鎖付加体 |
-
2013
- 2013-10-30 DK DK13857593.1T patent/DK2924053T3/da active
- 2013-10-30 EP EP13857593.1A patent/EP2924053B1/en active Active
- 2013-10-30 US US14/646,295 patent/US9708413B2/en active Active
- 2013-10-30 WO PCT/JP2013/079408 patent/WO2014080730A1/ja active Application Filing
- 2013-10-30 JP JP2014548498A patent/JP6211533B2/ja active Active
- 2013-10-30 CN CN201380070699.2A patent/CN104918962B/zh active Active
- 2013-10-30 KR KR1020157015751A patent/KR102227918B1/ko active IP Right Grant
- 2013-11-20 TW TW102142224A patent/TWI634127B/zh active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2924053A4 (en) | 2016-08-24 |
| KR102227918B1 (ko) | 2021-03-15 |
| TW201427999A (zh) | 2014-07-16 |
| EP2924053A1 (en) | 2015-09-30 |
| KR20150102003A (ko) | 2015-09-04 |
| TWI634127B (zh) | 2018-09-01 |
| US20150299337A1 (en) | 2015-10-22 |
| CN104918962A (zh) | 2015-09-16 |
| JPWO2014080730A1 (ja) | 2017-01-05 |
| CN104918962B (zh) | 2017-12-19 |
| JP6211533B2 (ja) | 2017-10-11 |
| US9708413B2 (en) | 2017-07-18 |
| WO2014080730A1 (ja) | 2014-05-30 |
| EP2924053B1 (en) | 2020-11-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2900752T3 (da) | Fugemasse, vægenhed og fremgangsmåder og produkter relateret dertil | |
| DK2934189T3 (da) | Humane mælkeoligosaccharider til reduktion af stress-symptomer | |
| CO7061071A2 (es) | Procesos para la preparación de (s)-1-(3-etoxi-4-metoxifenil)-2-metansulfoniletilamina | |
| DK3608325T3 (da) | Polycykliske-carbamoylpyridonforbindelser og deres farmaceutiske anvendelse | |
| DK2723887T3 (da) | Systemer, fremgangsmåder og indretinger til at opnå glykæmisk ligevægt | |
| DK2611785T3 (da) | N-(tetrazol-5yl)- og n- (triazol-5-yl) arylcarboxylsyreamider og deres anvendelse som herbicider | |
| ZA201503753B (en) | Pyrrole sulfonamide derivative, preparation method for same, and medical application thereof | |
| DK2838533T3 (da) | Sammensætninger og fremgangsmåder til at modulere 15-pgdh-aktivitet | |
| CO6781519A2 (es) | Equipo y procedimiento para exploración, diagnóstico y terapia de problemas funcionales de la visión | |
| DK2900645T3 (da) | Herbicidt aktive 3-phenylisoxazolinderivater | |
| DK2773633T3 (da) | Heterocykliske forbindelser, medikamenter indeholdende forbindelserne, anvendelse deraf og fremgangsmåder til fremstilling deraf. | |
| DK2809318T3 (da) | Ammoniumholdige sulfonsyre-, phosphonsyre- og carboxylsyrederivater og disses medicinske anvendelse | |
| CO6910193A2 (es) | Derivados de anilina, su preparación y su aplicación terapéutica | |
| DK2736888T3 (da) | 3-heteroaroylaminopropionsyrederivater og deres anvendelse som farmaceutika | |
| DK2920240T3 (da) | Fremgangsmåde til fremstilling af en vandig opløsning af chitosan, chitosansammensætning, chitosanaerosol, fremgangsmåde til fremstilling af en chitosanhydrogelmembran og fremgangsmåde til fremstilling af et chitosan-protein-biopolymermateriale | |
| CU20130003A7 (es) | Procedimiento de preparacion de la sal de l-arginina de perindoprilo. | |
| DK2864496T4 (da) | Euglobulin-baseret fremgangsmåde til bestemmelse af den biologiske aktivitet af defibrotid | |
| DK2896694T3 (da) | Saccharidoxidase og fremgangsmåde til fremstilling deraf og anvendelse deraf | |
| DK2786757T3 (da) | 2-substitueret oleanolsyre-derivat, fremgangsmåde til fremstilling af samme, og anvendelse deraf | |
| BR112014030277A2 (pt) | sistema médico | |
| BR112015003116A2 (pt) | preparação farmacêutica sólida contendo levotiroxina | |
| DK2924053T3 (da) | Glycosyleret linker, forbindelse, der indeholder glycosyleret linker-del og fysiologisk aktiv stofdel eller salt deraf, og fremgangsmåder til fremstilling af forbindelsen eller saltet deraf | |
| DK2871184T3 (da) | Benzodioxolderivat og fremgangsmåde til fremstilling og anvendelse deraf | |
| EP2926829A4 (en) | BINDED GLUCIDINE CHAIN, COMPOUND CONTAINING BINDED GLUCIDIC CHAIN BINDER AND PHYSIOLOGICALLY ACTIVE SUBSTANCE OR SALT THEREOF, AND PROCESS FOR PRODUCING THE SAME | |
| CO6811857A2 (es) | Derivados de 2-amino-3(imidazol-2-il)-piridin-4-ona, preparación de los mismos y uso terapéutico de los mismos |